EXUMA Biotech
Latest round
- Series B
Last raised
- Dec 2021
Total raised
- $97M
Investors
- 6
About EXUMA Biotech
EXUMA Biotech Corp.EXUMA Biotech Corp. was founded in 2015 in West Palm Beach, US.472 mn.EXUMA Biotech specializes in the development of innovative cell and gene therapies aimed at treating autoimmune diseases and various forms of cancer. The company's primary offerings include the rPOC Subcutaneous (SC) platform, engineered for the administration of autologous cell therapies without necessitating lymphodepleting chemotherapy. This technology allows for the reprogramming of a patient's own lymph nodes to facilitate in vivo CAR-T therapy, enhancing the efficacy and safety of treatment. EXUMA has also developed a CD3-Targeted lentivector that selectively targets and loads lymphocytes for subsequent transduction and expansion, alongside its FITNESS DRIVER transgene which optimizes effector cell characteristics.EXUMA Biotech generates revenue through a combination of partnerships and collaborations with healthcare providers and research institutions. The transaction structure typically involves direct agreements for the provision of their proprietary therapies, particularly focusing on their flagship product lines such as the TMR CAR-T product. Clients enter into contracts that outline the terms for usage and distribution of these therapies, often based on patient needs. Revenue streams include potential licensing agreements for their technologies and ongoing collaborations for clinical research., Ltd, Sinobioway Medicine, and SunTerra Capital. The funds will be utilized to further develop EXUMA's autologous subcutaneous rPOC CAR-TaNK platform targeting hematologic and solid tumors, as well as to continue clinical investigations of the Tumor Metabolism Regulated (TMR) CAR technology aimed at solid tumors. The company plans to expand into new markets, particularly in Europe and Asia, by the end of 2023.
Who invested in EXUMA Biotech
6 investors across 3 rounds
See all investors in EXUMA Biotech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about EXUMA Biotech
Who invested in EXUMA Biotech?
EXUMA Biotech has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has EXUMA Biotech raised?
EXUMA Biotech has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did EXUMA Biotech last raise money?
EXUMA Biotech's most recent round on record is a Series B, in Dec 2021.
What does EXUMA Biotech do?
EXUMA Biotech is a biotechnology company.
Where is EXUMA Biotech headquartered?
EXUMA Biotech is headquartered in West Palm Beach, US.
Which VCs invest in companies like EXUMA Biotech?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at EXUMA Biotech's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like EXUMA Biotech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.